$ACAD Headlines This tiny mutual fund is no. 1 for 2013

New Post Public Reply Private Reply Replies (0) Message Board

Jan 10, 2014 at 3:52 PM

$ACAD Headlines

This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Despite Fed concerns, technicals support bull case 1:16 p.m. Sept. 17, 2013 - Michael Ashbaugh
Despite Fed concerns, technicals support bull case 12:02 p.m. Sept. 17, 2013 - Michael Ashbaugh
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
Charting the S&P 500’s break to all-time highs 11:47 a.m. Aug. 6, 2013 - Michael Ashbaugh
Longer-term technical risk points higher 11:32 a.m. Aug. 6, 2013 - Michael Ashbaugh
7 gut checks before the stock market's opening bell 5:56 a.m. July 30, 2013 - Shawn Langlois
Charting a strong third-quarter start 11:23 a.m. July 16, 2013 - Michael Ashbaugh
Charting a strong third-quarter start 11:17 a.m. July 16, 2013 - Michael Ashbaugh
Looking for the choicest opportunity 12:37 p.m. June 11, 2013 - The Trading Deck
Declines often spell opportunity 1:11 p.m. June 6, 2013 - The Trading Deck
Don't fight the tape 10:27 a.m. May 28, 2013 - The Trading Deck
Charting the S&P’s uptrend, and its next hurdle 10:55 a.m. April 23, 2013 - Michael Ashbaugh
Charting the S&P’s uptrend, and its next hurdle 10:25 a.m. April 23, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Dow, S&P pull in from record highs 10:15 a.m. April 12, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 11:01 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 10:50 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 vies for record closing high 11:19 a.m. March 28, 2013 - Michael Ashbaugh
Acadia Pharma up 10% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi

Acadia slides as SA article paints grim picture 12:39 p.m. Jan. 7, 2014 - Seeking Alpha
Healthcare Stocks To Avoid This Year 10:08 a.m. Jan. 7, 2014 - Seeking Alpha
4 Stocks That Could See Significant Gains In 2014 2:35 p.m. Jan. 6, 2014 - Seeking Alpha
Acadia Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days 11:52 a.m. Jan. 6, 2014 - Seeking Alpha
A Tiny-Stock Fund Is No. 1 for 2013 4:28 p.m. Jan. 5, 2014 - WSJ.com
Top Stocks Of 2013 Run Gamut: Solar, Drugs, Tech, TV 5:59 p.m. Jan. 2, 2014 - Investors Business Daily
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Taking A Look At A Few Of The Top Performers Of 2013 12:27 p.m. Dec. 30, 2013 - Seeking Alpha
The Billion-Dollar Biotech Club: Speculation Trumped Risk 9:19 a.m. Dec. 30, 2013 - TheStreet.com
Acadia: The Best Hope For Parkinson's Psychosis Sufferers 4:21 p.m. Dec. 27, 2013 - Seeking Alpha
ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Health Care Laggard 5:01 p.m. Dec. 26, 2013 - TheStreet.com
Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond 8:01 a.m. Dec. 19, 2013 - Seeking Alpha
Understanding The Investment Opportunity In Developmental Biotechnology 6:31 p.m. Dec. 11, 2013 - Seeking Alpha
Lessons Learned From The Top 20 Stocks Of 2013 4:44 p.m. Dec. 11, 2013 - Seeking Alpha
ACADIA Pharmaceuticals' CEO Presents at Oppenheimer 24th Annual Healthcare Conference (Transcript) 2:06 p.m. Dec. 10, 2013 - Seeking Alpha
2013's Top Performers 6:56 p.m. Dec. 9, 2013 - Seeking Alpha
ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Drugs Winner 5:01 p.m. Dec. 4, 2013 - TheStreet.com
Why Acadia Is A Promising Investment 1:17 p.m. Dec. 4, 2013 - Seeking Alpha
ACADIA Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 3:18 p.m. Dec. 3, 2013 - Seeking Alpha
ACADIA Pharmaceuticals (ACAD) Highlighted As Today's Perilous Reversal Stock 10:00 a.m. Dec. 3, 2013 - TheStreet.com

Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch 8:00 a.m. Dec. 25, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola 8:00 a.m. Nov. 29, 2013 - PR Newswire
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 26, 2013 - BusinessWire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
Earnings, Trend Analysis: The Dow Chemical, Turquoise Hill Resources, ACADIA Pharmaceuticals, E Commerce China Dangdang, Yum! Brands 9:35 a.m. Nov. 15, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis 9:00 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:28 a.m. Nov. 7, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:01 p.m. Nov. 6, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Publication in The Lancet of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin 8:40 p.m. Oct. 31, 2013 - BusinessWire
Under The Radar Big Pharma Partnership Opportunity for Zalicus,Targacept and ACADIA 5:16 a.m. Oct. 31, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013 9:00 a.m. Oct. 30, 2013 - BusinessWire
Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano 9:00 a.m. Oct. 29, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 9:05 a.m. Oct. 21, 2013 - PR Newswire
Critical Alerts For SunPower, Starbucks, ACADIA Pharmaceuticals, Opko Health, and Cytokinetics Released By InvestorsObserver 9:31 a.m. Oct. 16, 2013 - PR Newswire
Reveal Insider Trading for Opko Health, ACADIA Pharmaceuticals, Synaptics, Intel, Charles Schwab, and Molycorp 8:55 a.m. Oct. 16, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elbit Systems Poised for Q3 2026 Earnings Reveal

Elbit Systems: A Strategic Player in Defense Here's what's going on with Elbit Systems Ltd. (NASDAQ:ESLT), the Israeli defense heavy hitter. They're gearing up to spill the beans on their Q3 financial results this November 17th. And for those of us keeping an eye on how defense contractors are adapting to today's chaotic geopolitical climate, this is a date you don't want...

Penske's Q3 2026: Revenue Up, Private Deal Awaits

Jumping straight into it, Penske Automotive Group (NYSE: PAG) just rolled out their quarterly numbers. The highlights? A 5% revenue bump, landing at $8.4 billion. That's nice, sure, but let's not get too cozy, there's a bigger elephant in this garage—it's the bold move to take the company private! Our old friend volatility still sends shivers down the spine of long-time...

Fidelis Care Opens $120K Workforce Grants for Aid

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

BlueNord Signals Strategic Shift with Vår Energi Merger

BlueNord's Bold Move in the Energy Sector With the ink barely dry on their third-quarter results, BlueNord has dropped a bombshell: a merger approved with Vår Energi. This isn't just another page in their corporate books—it's a strategic pivot that could redefine their place within the oil and gas arena. Anybody keeping an eye on the energy sector right now should sit...

Civitas Boosts Orlando Luxury Hotel with $386M Loan

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

AppGate Rises as 2026 Leader in Digital Risk

AppGate: Forging a Path in Digital Security In a world where cyber threats seem to lurk around every digital corner, snagging the title of a leader in digital risk protection from the SPARK Matrix is no small feat. Let’s dive deep into AppGate’s rise to the top in QKS Group’s 2026 evaluation. What Sets AppGate Apart? AppGate's leadership status isn't some overnight...

Scams vs Identity Theft: Trauma's Dark Impact Revealed

Facing the Dark Reality of Scams and Identity Theft Imagine facing a bleak financial horizon because of scams and identity theft, but the weight on your soul ain't about just numbers. That's what the Identity Theft Resource Center's 2026 Consumer Impact Report brings to light. We're talking about massive mental and emotional whirlwinds, way beyond mere dollars and cents....

Kong Joins Forces with ServiceNow for AI Governance

Shaping the Future of Enterprise AI When it comes to AI governance, it's not just about flashy tech jargon; it's about ensuring that enterprises can tread carefully and confidently in the AI arena. Kong, the AI Connectivity Company, is making a significant move by teaming up with ServiceNow in what's been dubbed the ServiceNow Control Tower Alliance. This collaboration...

Royce Small-Cap Trust Shows Resilience Amid Volatility

A Closer Look at Royce's Latest Moves Royce Small-Cap Trust (NYSE: RVT), the venerable old timer in the small-cap fund world, has been trucking along the market's bumpy byways since forever ago. With over 50 years of small- and micro-cap investment experience under its belt, you'd think it might have seen everything by now. But in the volatile world of small caps,...

Ascletis' ASC30 Achieves Significant HbA1c Reductions

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...